1	20 concomitant use of vigabatrin subject who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin associate clinically significant abnormality in a visual perimetry test|vigabatrin[22,32]|||||||5 month[114,121]||C0048044|14851|14851|vigabatrin
1	20 concomitant use of vigabatrin subject who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin associate clinically significant abnormality in a visual perimetry test|vigabatrin[50,60]|||||||||C0048044|14851|14851|vigabatrin
1	20 concomitant use of vigabatrin subject who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin associate clinically significant abnormality in a visual perimetry test|vigabatrin[85,95]|||||||||C0048044|14851|14851|vigabatrin
1	20 concomitant use of vigabatrin subject who take vigabatrin in the past must be off vigabatrin for approximately 5 month prior to visit 1 and must have documentation show no evidence of a vigabatrin associate clinically significant abnormality in a visual perimetry test|vigabatrin[189,199]|||||||||C0048044|14851|14851|vigabatrin
